Medicale (MCLE) EBIAT (2020 - 2025)
Medicale's EBIAT history spans 6 years, with the latest figure at -$10670.0 for Q3 2025.
- For Q3 2025, EBIAT rose 36.79% year-over-year to -$10670.0; the TTM value through Sep 2025 reached -$41153.0, up 29.31%, while the annual FY2025 figure was -$41153.0, 29.31% up from the prior year.
- EBIAT reached -$10670.0 in Q3 2025 per MCLE's latest filing, down from -$5528.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$5528.0 in Q2 2025 to a low of -$19307.0 in Q4 2023.
- Average EBIAT over 5 years is -$10650.6, with a median of -$8537.0 recorded in 2023.
- Peak YoY movement for EBIAT: skyrocketed 55.82% in 2022, then tumbled 133.77% in 2023.
- A 5-year view of EBIAT shows it stood at -$18696.0 in 2021, then surged by 55.82% to -$8259.0 in 2022, then crashed by 133.77% to -$19307.0 in 2023, then increased by 13.61% to -$16680.0 in 2024, then soared by 36.03% to -$10670.0 in 2025.
- Per Business Quant, the three most recent readings for MCLE's EBIAT are -$10670.0 (Q3 2025), -$5528.0 (Q2 2025), and -$8275.0 (Q1 2025).